## **Core Concept**
Mantle cell lymphoma (MCL) is a subtype of B-cell lymphoma characterized by a specific genetic abnormality, the t(11;14) translocation, leading to overexpression of cyclin D1. This malignancy typically expresses specific surface markers and proteins that can be used for diagnosis. The key to distinguishing MCL from other lymphomas lies in its unique immunophenotypic profile.

## **Why the Correct Answer is Right**
MCL cells are known to express B-cell markers such as CD19, CD20, and CD22. They are also characteristically positive for CD5, which is a marker often associated with T-cells but can be found on certain B-cell subsets, including MCL. Cyclin D1 overexpression, resulting from the t(11;14) translocation, is a hallmark of MCL and can be used as a diagnostic marker. However, MCL typically lacks or shows weak expression of CD10, a marker often used to distinguish between germinal center-derived lymphomas (which are usually CD10 positive) and those derived from post-germinal center or mantle zone B-cells.

## **Why Each Wrong Option is Incorrect**
- **Option A:** CD20 is a common B-cell marker expressed in MCL, making it incorrect as an exception.
- **Option B:** CD5 is expressed in MCL, distinguishing it from other B-cell lymphomas like follicular lymphoma, making this option incorrect.
- **Option C:** Cyclin D1 overexpression is characteristic of MCL due to the t(11;14) translocation, making this option incorrect.

## **Why Option D is Correct**
- **Option D:** CD10 is typically **weakly positive or negative** in MCL. This contrasts with other types of lymphomas, such as follicular lymphoma, which are usually CD10 positive. The lack of strong CD10 expression is a key feature that helps differentiate MCL from other B-cell lymphomas.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for MCL is the association with the t(11;14) translocation and cyclin D1 overexpression. MCL often presents with lymphocytosis, lymphadenopathy, and can involve the bone marrow and gastrointestinal tract. The distinction from other lymphomas, particularly those with similar immunophenotypic profiles like chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and follicular lymphoma, relies on a combination of clinical features, histopathology, and immunophenotyping.

## **Correct Answer: D. CD10**